Trial Profile
A Phase 3 Study of JNS013 in Patients With Chronic Pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Oct 2013
Price :
$35
*
At a glance
- Drugs Tramadol/paracetamol (Primary)
- Indications Back pain; Musculoskeletal pain
- Focus Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 24 Mar 2012 Results presented at the 2012 IOF World Congress on Osteoporosis and 11th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis.
- 18 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Apr 2009 Patient number amended from 252 to 321 as reported by ClinicalTrials.gov.